Life Science & Biotech

ARTICLES

Indy hospitals stung by Medicare penalties for patient injuries

Five Indianapolis-area hospitals stand to lose more than $7 million in Medicare payments as a penalty for having rates of infections and patient injuries that run higher than most hospitals nationwide.
Read More

Zimmer to pay Stryker $70M in surgical device fight

The award is actually less than a third of what Warsaw-based Zimmer was originally ordered to pay for infringing patents on a lavage device.
Read More

IU Health's new sense of urgency

Indiana University Health will open a dozen urgent care clinics in the Indianapolis area in the next two years, which will nearly double the number of hospital-affiliated urgent care centers in central Indiana. Here's why we're likely to see even more in the future.
Read More

Pence: HIP 2.0 timeline not as important as approval

The state and federal government have been in negotiations since the summer, but the governor said he remains confident that an agreement will be reached, even if it isn’t by his original deadline.
Read More

Hoosiers accuse Anthem of 'unjust enrichment'

The reason competition is so low and prices so high in Indiana’s health insurance market is that Anthem Blue Cross and Blue Shield has participated in a vast conspiracy to inflate prices, according a federal lawsuit that Anthem called "baseless."
Read More

The moving target bedeviling attempts to cut health care costs

In health care, 5 percent of patients account for 50 percent of costs. Trouble is, those patients aren't the same from year to year. Not even close.
Read More

Hoosier docs, hospitals cut jobs while peers nationally keep hiring

In spite of the divergent trend, Indiana still employs more workers in hospitals and doctors’ offices than the nation as a whole.
Read More

Feds drop case against former Lilly scientists accused of stealing secrets

Federal prosecutors dropped all charges against two scientists accused of stealing trade secrets worth $55 million from Eli Lilly and Co. after new information emerged last month, according to a court motion made Friday.
Read More

Growth-minded Vertellus buys Dow Chemical unit

Indianapolis-based chemical producer Vertellus Specialties Inc. has announced its second big acquisition in as many months, in a deal believed to be worth as much as $200 million.
Read More

Regrets of ending an employer health plan

This spring, Keith Pitzele ended his company’s health plan and sent his workers to the Obamacare exchange. It was a bumpy experience he’s glad he won’t have to repeat next year. Does that mean most employers won't follow suit?
Read More